| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-leukemia effect associated with down-regulated CD47 and up-regulated calreticulin by stimulated macrophages in co-culture
|
Hassan, Eman M.
|
|
|
70 |
3 |
p. 787-801
|
artikel
|
| 2 |
Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE)
|
Thakur, Archana
|
|
|
70 |
3 |
p. 633-656
|
artikel
|
| 3 |
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)
|
Chandra, J.
|
|
|
70 |
3 |
p. 743-753
|
artikel
|
| 4 |
A systematic scoping review on natural killer cell function in colorectal cancer
|
Reid, Fiona S. W.
|
|
|
70 |
3 |
p. 597-606
|
artikel
|
| 5 |
Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives
|
Qu, Jingjing
|
|
|
70 |
3 |
p. 619-631
|
artikel
|
| 6 |
Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer
|
Toor, Salman M.
|
|
|
70 |
3 |
p. 803-815
|
artikel
|
| 7 |
Downregulated ATP6V1B1 expression acidifies the intracellular environment of cancer cells leading to resistance to antibody-dependent cellular cytotoxicity
|
Nishie, Mariko
|
|
|
70 |
3 |
p. 817-830
|
artikel
|
| 8 |
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab
|
Kijima, Toshiki
|
|
|
70 |
3 |
p. 657-665
|
artikel
|
| 9 |
Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study
|
Jiang, Haiping
|
|
|
70 |
3 |
p. 857-868
|
artikel
|
| 10 |
Flow cytometric analysis of circulating endothelial cells and endothelial progenitor cells in pediatric solid tumors: prognostic impact on treatment response and survival
|
Sayed, Heba Abdel Razik
|
|
|
70 |
3 |
p. 755-761
|
artikel
|
| 11 |
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient
|
Anghileri, Elena
|
|
|
70 |
3 |
p. 831-842
|
artikel
|
| 12 |
Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study
|
Wang, Qinchuan
|
|
|
70 |
3 |
p. 701-712
|
artikel
|
| 13 |
Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodies
|
Frelau, Alexandra
|
|
|
70 |
3 |
p. 679-687
|
artikel
|
| 14 |
Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies
|
Zhang, Wei
|
|
|
70 |
3 |
p. 689-700
|
artikel
|
| 15 |
Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma
|
Nguyen, Rosa
|
|
|
70 |
3 |
p. 721-732
|
artikel
|
| 16 |
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas
|
Landsburg, Daniel J.
|
|
|
70 |
3 |
p. 869-874
|
artikel
|
| 17 |
PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures
|
Appleton, Kathryn M.
|
|
|
70 |
3 |
p. 843-856
|
artikel
|
| 18 |
Pembrolizumab and atezolizumab in triple-negative breast cancer
|
Kwapisz, Dorota
|
|
|
70 |
3 |
p. 607-617
|
artikel
|
| 19 |
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors
|
Papadopoulos, Kyriakos P.
|
|
|
70 |
3 |
p. 763-772
|
artikel
|
| 20 |
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase
|
Xiong, Qi
|
|
|
70 |
3 |
p. 713-720
|
artikel
|
| 21 |
Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study
|
Zahran, Asmaa M.
|
|
|
70 |
3 |
p. 733-742
|
artikel
|
| 22 |
Systematic analysis of immune-related genes based on a combination of multiple databases to build a diagnostic and a prognostic risk model for hepatocellular carcinoma
|
Wen, Di-guang
|
|
|
70 |
3 |
p. 773-786
|
artikel
|
| 23 |
Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
|
Adderley, H.
|
|
|
70 |
3 |
p. 589-595
|
artikel
|
| 24 |
Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma
|
Yang, Huayu
|
|
|
70 |
3 |
p. 667-677
|
artikel
|
| 25 |
Varied functions of immune checkpoints during cancer metastasis
|
Safarzadeh, Ali
|
|
|
70 |
3 |
p. 569-588
|
artikel
|
Tijdschrift beschrijving